IPO market

Unlisted Ideas

Invest in Pre-IPO shares

IPO Ideas

Invest in IPO in just 3 clicks

About Us

Aptus Pharma IPO listing date & price

BBSMEBSEListed

Listed at

80.8

+15.43%

Aptus Pharma IPO is a SME book building IPO. Issue size is 13.02 Cr. Price band is ₹65 to ₹70 per share. Minimum investment is ₹2.80 L. Lot size is 2000 shares. Open from 23 Sept 2025 to 25 Sept 2025. Allotment on 26 Sept 2025. Listing on 30 Sept 2025 at BSE. Managed by Interactive Financial Services Ltd. Registrar: Bigshare Services Pvt Ltd. Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents: RHP and DRHP.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Aptus Pharma IPO listing date & price

BBSMEBSEListed

Listed at

80.8

+15.43%

Official documents: RHP and DRHP.

Aptus Pharma IPO — listing

Official listing price and performance versus the issue price, after the stock debuts on the exchange.

Listing snapshot

Official listing versus the issue price for this debut.

Listing price

₹80.8

Vs issue price

+15.43%

Gain

Issue price

₹70

How to read this

Listing performance is the percentage move from the issue price to the first official exchange print. It reflects market pricing at listing, not advice about future returns.

Aptus Pharma IPO listing FAQs

How listing price and listing performance work.

What is the Aptus Pharma IPO listing price?

The Aptus Pharma IPO listing price is the price at which the company's shares are listed on the stock exchange after the IPO allotment process. It may be at a premium or discount to the issue price depending on market demand and sentiment.

When is the Aptus Pharma IPO listing date?

The Aptus Pharma IPO listing date is the date when the company's shares are listed on the stock exchanges (NSE/BSE) and become available for trading. It is usually announced after the allotment process is completed.

What is the Aptus Pharma IPO allotment date?

The Aptus Pharma IPO allotment date is when the company finalizes share allocation to applicants. After allotment, you can check your status on the registrar's portal using your application number, PAN, or DP ID.

What is listing gain or loss in Aptus Pharma IPO?

Listing gain or loss is the difference between the listing price and the issue price. A positive listing gain means the share listed above the issue price; a loss means it listed below. Past listing performance does not guarantee future results.

Where can I check Aptus Pharma IPO allotment status?

You can check Aptus Pharma IPO allotment status on the registrar's website or the exchange portal once allotment is finalized. You will need your application number, PAN, or DP ID/Client ID to verify your allotment.

How is the Aptus Pharma IPO listing price determined?

The Aptus Pharma IPO listing price is determined by market demand and supply on the listing day. Factors include subscription response, company fundamentals, sector sentiment, and overall market conditions.

Can the Aptus Pharma IPO listing price differ from the issue price?

Yes, the Aptus Pharma IPO listing price can be different from the issue price. It may list at a premium (above issue price) or at a discount (below issue price) depending on market conditions at the time of listing.

How is listing performance calculated for Aptus Pharma IPO?

Listing performance for Aptus Pharma IPO is calculated as the percentage change from the issue price to the listing price. It is for informational purposes only and does not guarantee similar outcomes for other IPOs.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Explore IPO market for more details

Aptus Pharma IPO — listing

Official listing price and performance versus the issue price, after the stock debuts on the exchange.

Listing snapshot

Official listing versus the issue price for this debut.

Listing price

₹80.8

Vs issue price

+15.43%

Gain

Issue price

₹70

How to read this

Listing performance is the percentage move from the issue price to the first official exchange print. It reflects market pricing at listing, not advice about future returns.